|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
FY2020
12 months to Dec 31, 2020
|
FY2019
12 months to Dec 31, 2019
|
FY2018
12 months to Dec 31, 2018
|
|
|---|---|---|---|---|---|
| Cash flows from operating activities: | |||||
| Net loss | |||||
| Adjustments to reconcile net loss to net cash used in operating activities: | |||||
| Depreciation and amortization | |||||
| Gain on forgiveness of PPP loan | |||||
| Amortization of deferred financing costs | |||||
| Non-cash interest | |||||
| Provision for doubtful accounts receivable | |||||
| Inventory impairment | |||||
| Stock-based compensation | |||||
| Unrealized foreign exchange on intercompany payables | |||||
| Settlement gain | |||||
| Changes in operating assets and liabilities: | |||||
| Accounts receivable | |||||
| Inventory | |||||
| Prepaid expenses and other assets | |||||
| Accounts payable and accrued expenses | |||||
| Net cash used in operating activities | |||||
| Cash flows from investing activities: | |||||
| Purchases of property and equipment | |||||
| Purchases of intangibles and other assets | |||||
| Proceeds from sale of equipment | |||||
| Divestiture of Surgical product line | |||||
| Net cash (used in)/provided by investing activities | |||||
| Cash flows from financing activities: | |||||
| Proceeds from exercise of stock options | |||||
| Proceeds from exercise of warrants | |||||
| Proceeds from issuance of common stock | |||||
| Proceeds from senior secured term loans | |||||
| Proceeds from long-term debt | |||||
| Shares forfeited for tax obligation in connection with restricted stock units | |||||
| Payments of deferred financing costs | |||||
| Payment of long-term debt | |||||
| Repayments of senior secured notes | |||||
| Net cash provided by financing activities | |||||
| Effect of exchange rate changes on cash | |||||
| Net increase in cash, cash equivalents and restricted cash | |||||
| Cash, cash equivalents and restricted cash at beginning of year | |||||
| Cash, cash equivalents and restricted cash at end of year | |||||
| Supplemental disclosure of cash flow information: | |||||
| Cash paid for interest | |||||
| Cash paid for income taxes | |||||
| Right-of-use assets recognized in exchange for new lease obligations (non-cash) | |||||
| Right-of-use assets recognized in exchange for lease obligations (non-cash) | |||||
| Gain on forgiveness of PPP loan (non-cash) | |||||
| Issuance of common stock for convertible debt interest (non-cash) | |||||
| Issuance of common stock for conversion of convertible debt (non-cash) | |||||
Loading...